Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Trial Underway Testing Cancer Drug as Covid-19 Therapy

SARS-CoV-2 and cell

A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections. . . . → Read More: Trial Underway Testing Cancer Drug as Covid-19 Therapy

Infographic – Covax Begins Vaccine Deliveries

Chart: Covax deliveries

Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries

Joint Venture Developing Oral Covid-19 Vaccine

Capsules in a glass

Two biotechnology companies are forming a new enterprise to produce a vaccine as a capsule or tablet to protect against Covid-19 infections. . . . → Read More: Joint Venture Developing Oral Covid-19 Vaccine

Infographic – China Remains Top U.S. Student Source

Chart: international students

China continues to provide the largest number of international students on American campuses, sending more than 369,000 of its citizens, an increase of almost 2 percent over the previous year. . . . → Read More: Infographic – China Remains Top U.S. Student Source

AstraZeneca Joins $1B Fund, Expands Footprint in China

Research lab in China

The pharmaceutical company AstraZeneca is starting a joint $1 billion health care investment fund in China and vastly increasing its labs and offices there. . . . → Read More: AstraZeneca Joins $1B Fund, Expands Footprint in China

Safe, Economical Method Devised to Make Graphene

Eucalyptus trees

Researchers in Australia and India developed a safer and much less costly process for synthesizing the super-material graphene using an extract from eucalyptus bark. . . . → Read More: Safe, Economical Method Devised to Make Graphene

FDA Approves Pediatric HIV Drug Formulation

Scanning electron micrograph of HIV particles infecting a human T cell (NIH.gov)

5 June 2015. The U.S. Food and Drug Administration approved an application for a current HIV drug formulated to better treat infections in infants and young children, especially in limited resource regions. The formulation is a combination of lopinavir and ritonavir . . . → Read More: FDA Approves Pediatric HIV Drug Formulation

XPrize Awards $5.25M for Lunar Technologies

(NASA.gov)

26 January 2015. A competition to develop new technologies for landing and robotic exploration of the moon awarded $5.25 million in 9 prizes to 5 private companies, as part of the Google Lunar XPrize challenge. The companies — from the U.S., Germany, Japan, and India — received the prizes for their design . . . → Read More: XPrize Awards $5.25M for Lunar Technologies

University Starts Computer Science/Brain Research Consortium

3-D brain wiring illustration (NIH)

26 August 2014. Carnegie Mellon University in Pittsburgh organized an international consortium of researchers to apply computer science techniques to the study of brain research and behavior. The collaboration, known as BrainHub, includes researchers from nearby University of Pittsburgh, as well as Sun Yat-sen University in Guangzhou, China, . . . → Read More: University Starts Computer Science/Brain Research Consortium

Cisco Venture Arm Backing Internet-of-Things Start-Ups

(Daniel Borman/Flickr)

1 May 2014. Cisco Investments, the venture capital division of the network technologies company, is taking minority stakes in start-up companies and an accelerator that add Internet connectivity to everyday devices and products, known as Internet-of-Things. The company also plans to make $150 million in early-stage investments over the next two . . . → Read More: Cisco Venture Arm Backing Internet-of-Things Start-Ups